Prescription drug · ANDA
sacubitril and valsartan NDC 70771-1923
Sacubitril 97 mg/1; Valsartan 103 mg/1 · Tablet · Oral · Zydus Lifesciences Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70771-1923-4 | 70771192304 | 10 BLISTER PACK in 1 CARTON (70771-1923-4) / 10 TABLET in 1 BLISTER PACK (70771-1923-2)Marketed from Jul 8, 2025 | |
| 70771-1923-6 | 70771192306 | 60 TABLET in 1 BOTTLE (70771-1923-6)Marketed from Jul 8, 2025 | |
| 70771-1923-8 | 70771192308 | 180 TABLET in 1 BOTTLE (70771-1923-8)Marketed from Jul 8, 2025 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- sacubitril and valsartan
- Generic name (nonproprietary)
- sacubitril and valsartan
- Active ingredients
- Sacubitril — 97 mg/1Valsartan — 103 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Zydus Lifesciences LimitedNDC labeler code 70771
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 213719
- Marketing start
- Listing expires
- Other FDA classes
- Angiotensin 2 Receptor Antagonists (Mechanism)Neprilysin Inhibitors (Mechanism)
- Identifiers
- Product ID 70771-1923_f0d8c298-2823-4537-ae02-c43da2c66e67SPL ID f0d8c298-2823-4537-ae02-c43da2c66e67SPL set ID 4c871c01-0564-411f-87e2-478aa42503cfRxCUI 1656340, 1656349, 1656354UNII 80M03YXJ7I, 17ERJ0MKGI
- Pharmacologic class
- Angiotensin 2 Receptor Blocker; Neprilysin Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470771192304followed by a unit qualifier and the quantityPackage 70771-1923-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
About NDC 70771-1923
- What is NDC 70771-1923?
- 70771-1923 is the product NDC for sacubitril and valsartan, Sacubitril 97 mg/1; Valsartan 103 mg/1 tablet, listed with the FDA by Zydus Lifesciences Limited. It has 3 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- sacubitril and valsartan.
- What is the active ingredient?
- Sacubitril, Valsartan.
- Who is the labeler?
- Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for sacubitril and valsartan?
- 86 other product NDCs are listed under this name. See all sacubitril and valsartan NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other sacubitril and valsartan products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Sacubitril and Valsartan | Sacubitril 24 mg/1; Valsartan 26 mg/1 | Tablet, Film coatedOral | Umedica Laboratories USA Inc. | 60290-085 | 60290-0085-0160290-0085-0260290-0085-03 |
| Sacubitril and Valsartan | Sacubitril 49 mg/1; Valsartan 51 mg/1 | Tablet, Film coatedOral | Umedica Laboratories USA Inc. | 60290-086 | 60290-0086-0160290-0086-0260290-0086-03 |
| Sacubitril and Valsartan | Sacubitril 97 mg/1; Valsartan 103 mg/1 | Tablet, Film coatedOral | Umedica Laboratories USA Inc. | 60290-087 | 60290-0087-0160290-0087-0260290-0087-03 |
| Sacubitril and Valsartan | Sacubitril 24 mg/1; Valsartan 26 mg/1 | Tablet, Film coatedOral | NorthStar RxLLC | 72603-880 | 72603-0880-0172603-0880-02 |
| Sacubitril and Valsartan | Sacubitril 49 mg/1; Valsartan 51 mg/1 | Tablet, Film coatedOral | NorthStar RxLLC | 72603-881 | 72603-0881-0172603-0881-02 |
| Sacubitril and Valsartan | Sacubitril 97 mg/1; Valsartan 103 mg/1 | Tablet, Film coatedOral | NorthStar RxLLC | 72603-882 | 72603-0882-0172603-0882-02 |
| sacubitril and valsartan | Sacubitril 24 mg/1; Valsartan 26 mg/1 | Tablet, Film coatedOral | Golden State Medical Supply, Inc. | 51407-935 | 51407-0935-10 |
| sacubitril and valsartan | Sacubitril 49 mg/1; Valsartan 51 mg/1 | Tablet, Film coatedOral | Golden State Medical Supply, Inc. | 51407-936 | 51407-0936-10 |
| sacubitril and valsartan | Sacubitril 97 mg/1; Valsartan 103 mg/1 | Tablet, Film coatedOral | Golden State Medical Supply, Inc. | 51407-937 | 51407-0937-10 |
| Sacubitril and Valsartan | Sacubitril 49 mg/1; Valsartan 51 mg/1 | Tablet, Film coatedOral | American Health Packaging | 60687-966 | 60687-0966-57 |
Other NDCs under ANDA 213719
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| sacubitril and valsartan | Sacubitril 24 mg/1; Valsartan 26 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 70710-1272 |
| sacubitril and valsartan | Sacubitril 49 mg/1; Valsartan 51 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 70710-1273 |
| sacubitril and valsartan | Sacubitril 97 mg/1; Valsartan 103 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 70710-1274 |
| sacubitril and valsartan | Sacubitril 24 mg/1; Valsartan 26 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1921 |
| sacubitril and valsartan | Sacubitril 49 mg/1; Valsartan 51 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1922 |